Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
12/2005
12/06/2005US6972295 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
12/06/2005US6972290 Piperazine derivatives and their use as anti-inflammatory agents
12/01/2005WO2005113519A1 Compounds and compositions as ppar modulators
12/01/2005WO2005112945A2 Synthesis of tetracyclines and analogues thereof
12/01/2005WO2005060456A3 Method for treating adamts-5-associate disease
12/01/2005US20050267206 Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
12/01/2005US20050267190 Solid-state form of celecoxib having enhanced bioavailability
12/01/2005US20050267182 Urea derivatives as FLT-3 modulators
12/01/2005US20050267175 Anticancer agents for, lungs, leukemia and ovarian cancer or prostate glands
12/01/2005CA2767912A1 Synthesis of tetracyclines and analogues thereof
12/01/2005CA2564429A1 Compounds and compositions as ppar modulators
11/2005
11/30/2005EP1600442A1 Heteroarylcarbamoylbenzene derivative
11/30/2005EP1124827B1 3-(substituted phenyl)-5-(substituted heterocyclyl)-1,2,4-triazole compounds
11/30/2005EP1091943B1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
11/30/2005CN1703395A Aryl and heteroaryl compounds and methods to modulate coagulation
11/29/2005US6969713 Piperidine and piperazine acetamide derivatives
11/29/2005US6969710 Compounds
11/24/2005WO2005110971A1 Heteroaryl substituted cyclohexyl-1,4-diamine derivatives
11/24/2005WO2005092011A3 Mitotic kinesin inhibitors
11/24/2005US20050261503 Heteroaromatic glucokinase activators
11/24/2005US20050261315 tyrosine kinase inhibitors such as N-(3-tert-butylisoxazol-5-yl)-2-(4-(benzyloxy)phenyl)acetamide, used for treating and preventing conditions and diseases, such as cancer, hematologic malignancies, cardiovascular disease, inflammation or multiple sclerosis
11/24/2005US20050261291 1-Cyclopropylmethyl-4-[2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine or a salt or hydrate; exhibit excellent cell adhesion inhibitory action or cell infiltration inhibitory action; for treating inflammatory diseases and autoimmune diseases such as inflammatory bowel diseases and rheumatoid arthritis
11/24/2005US20050261276 Novel sulphones for inhibition of gamma secretase
11/24/2005US20050261273 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
11/24/2005CA2566212A1 Heteroaryl-substituted cyclohexyl-1,4-diamine derivatives
11/23/2005EP1597243A1 Heterocyclic compounds useful as nurr-1 activators
11/23/2005EP1372645B1 Reconstitutable parenteral composition containing a cox-2 inhibitor
11/23/2005CN1228332C Chemical synthesis method of 3-(2-chlorophenyl)-5-methyl-4-isoxazole formyl chloride
11/23/2005CN1228327C Carboxylic acid derivatives and drugs containing the same
11/17/2005WO2005108347A2 Substituted enaminones, their derivatives and uses thereof
11/17/2005WO2005107762A2 Certain chemical entities, compositions, and methods
11/17/2005CA2565695A1 Certain chemical entities and compositions for use in the treatment of a cellular proliferative disease or disorder
11/16/2005EP1594846A1 Bis(hetero)aryl carboxamide derivatives for use as pgi2 antagonists
11/16/2005EP1594508A2 Novel bicyclic compounds and compositions
11/16/2005EP1594505A2 Phenylglycine derivatives useful as serine protease inhibitors
11/16/2005CN1227244C Herbicidal benzoyl derivatives
11/16/2005CN1227012C Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors
11/15/2005US6965036 Intermediates for guanidine mimics as factor Xa inhibitors
11/15/2005US6964983 Compounds that modulate PPAR activity and methods for their preparation
11/15/2005US6964978 Dissolving with crystal growth inihibitos; drying
11/15/2005US6964975 Isoxazole and thiazole compounds and use thereof as medicine
11/10/2005WO2005105770A2 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
11/10/2005WO2005105764A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/10/2005WO2005105744A1 Histamine-3 receptor antagonists
11/10/2005WO2005105733A1 Ortho substituted aryl or heteroaryl amide compounds
11/10/2005WO2005082871A3 Guanidine compounds, and use thereof as binding partners for 5-ht5 receptors
11/10/2005US20050250826 Compounds, compositions, processes of making, and methods of use related to inhibiting macrophage migration inhibitory factor
11/10/2005US20050250822 Substituted benzanilide compound and noxious organism controlling agent
11/10/2005US20050250818 Ortho substituted aryl or heteroaryl amide compounds
11/10/2005US20050250816 Positive allosteric modulators of the nicotinic acetylcholine receptor
11/10/2005CA2565184A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/10/2005CA2564258A1 Histamine-3 receptor antagonists
11/10/2005CA2562176A1 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
11/09/2005EP1593677A2 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes
11/09/2005EP1593671A1 DPP-IV inhibitors
11/09/2005EP1501787B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists
11/09/2005EP1216223B1 Novel dicarboxylic acid derivatives with pharmaceutical properties
11/09/2005EP1095016B1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
11/09/2005EP0979226B1 Isoxazole derivatives
11/08/2005US6962935 Anticoagulants; thrombosis therapy; cardiovascular disorders
11/08/2005CA2155104C Heterocyclic-substituted alkyl amide acat inhibitors
11/03/2005WO2005102980A1 Novel compounds, the preparation and the use thereof for a regiospesific synthesis of perfluor(alkyl) group heterocycles
11/03/2005WO2004099165A3 Heterocyclic compounds and hydro isomers thereof
11/03/2005US20050245747 e.g. 2-[2-(5-chloro-benzo[b]thiophen-2-yl)-phenylmethanesulfinyl]-acetamide; autoimmune disorders, antidepressant; narcolepsy, Parkinson's, Alzheimer's disease; attention deficit hyperactivity disorder; sleep disorder, fatigue
11/03/2005US20050245592 2-Iminopyrrolidine derivatives
11/03/2005US20050245543 Histamine-3 receptor antagonists
11/02/2005EP1590321A2 Aryl alkyl carbamate derivatives production and use thereof in therapy
11/02/2005EP1085016B1 Heterocycle-bearing thio phenol compounds, intermediates for the preparation of the same and processes for the preparation of both
11/02/2005CN1691944A Oxadiazoles as modulators of metabotropic glutamate receptor-5
11/02/2005CN1690050A Aryl-substituted iso-oxazoline compounds used as bactericide
11/01/2005US6960688 Use of compounds for the elevation of pyruvate dehydrogenase activity
11/01/2005US6960614 Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids
11/01/2005US6960607 Naphthyl benzoxazoles and benzisoxazoles as estrogenic agents
11/01/2005CA2177586C 4-benzoylisoxazoles and their use as herbicides
10/2005
10/27/2005WO2005100308A1 Thio-substituted biaryl-methanesulfinyl derivatives
10/27/2005WO2005100298A1 Cetp inhibitors
10/27/2005WO2005034848A3 Inhibitors of cathepsin s
10/27/2005WO2005021515B1 Inhibitors of phosphodiesterase type-iv
10/27/2005WO2004089366A8 Bicyclic compounds as nr2b receptor antagonists
10/27/2005US20050240023 Cathepsin cysteine protease inhibitors
10/27/2005US20050239899 Beta-secretase inhibitors
10/27/2005US20050239769 Therapeutic compounds for treating dyslipidemic conditions
10/27/2005US20050239751 e.g. tert-Butyl 6-(2-(3-(2,6-Dichlorophenyl)isoxazol-5-yl)pyridin-4-ylamino)-2-methyl-4-oxohexan-3-ylcarbamate; Hepatitis C virus (HCV) infections
10/27/2005CA2562082A1 Cetp inhibitors for the treatment and prevention of atherosclerosis
10/26/2005EP1589007A2 5-membered heterocycle derivatives, production thereof and their use as medicaments
10/26/2005CN1688545A Phosphodiesterase 4 inhibitors, including n-substituted phenylamine and diphenylamine analogs
10/26/2005CN1688527A Fused benzene derivative and use
10/26/2005CN1688315A Use of selective COX-2 inhibitors for the treatment of urinary incontinence
10/25/2005US6958356 Guanidine mimics factor Xa inhibitors
10/25/2005US6958355 Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
10/25/2005US6958331 sulfonyl amine derivatives such as {2-(2,2-diphenyl-ethylamino)-5-[4-(4-isopropyl-piperazine-1-carbonyl)-piperidine-1-sulfonyl]-phenyl}-morpholin-4-yl-methanone; pain, inflammation, septic shock
10/20/2005WO2005097765A1 Anaplastic lymphoma kinase modulators and methods of use
10/20/2005WO2005097760A1 Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses
10/20/2005WO2005097751A2 Non-imidazole heterocyclic compounds as histamine h3-receptor ligands
10/20/2005WO2005066143A3 Benzo[d]isoxazol-3-ol daao inhibitors
10/20/2005WO2005058845A3 Novel glucagon antagonists/inverse agonists
10/20/2005WO2005055715A3 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives
10/20/2005WO2005051931A3 Phosphodiesterase inhibitors
10/20/2005US20050234111 D-homo-17-chlor-16(17)-ene steroids
10/20/2005US20050234106 1-aryl-1-heteroarylaminoalkylene-substituted, e.g., 1-[fluorophenylcyclohexylmethyl]isoquinolin-1-ylamine; antiarrhythmia agents; cardiovascular disorders
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 115